@FiercePharma: Which pharma brands do docs trust most? Advair (GSK), Humira (AbbVie), Enbrel (Amgen/Pfizer) among them, says survey. More | Follow @FiercePharma
@AlisonBFierce: Protein Sciences uses cells from the ovaries of armyworms to make the active ingredient in Flublok. Story | Follow @AlisonBFierce
> Abbott Laboratories' ($ABT) fourth-quarter results offer optimism for the success of its newly spun-off pharma unit, AbbVie ($ABBV); lead product Humira saw a 23% sales gain, and other brands performed well. Report
> Nuvigil, the wakefulness drug from Teva Pharmaceutical Industries ($TEVA), failed its second trial in patients with bipolar depression, after hitting goal in its first depression trial. Report
> French drugmaker Pierre Fabre failed to persuade U.K. gatekeepers that its drug Javior is cost-effective as a bladder cancer treatment. Report
> Massachusetts is reviewing its policy on generic drug substitution to prepare for biosimilar versions of biotech drugs. Report
> India's pharma market is expected to grow at 14% to 17% annually through 2016, putting it among the top 5 emerging drug markets. Report
> Amgen ($AMGN) is one of the U.S. companies that is keeping cash declared as "indefinitely invested" overseas in U.S. bank accounts. Report (sub. req.)
@FierceMedDev: Quest posts 24% Q4 profit drop amid restructuring. More | Follow @FierceMedDev
@DamianFierce: $JNJ knew about hip implant failure concerns two years before recalling the all-metal devices. News | Follow @DamianFierce
> Abbott faces slumping stent sales in drug-free future. Report
> After FDA ban, Hospira creeps back into the infusion game with Q Core deal. Story
Biotech News
@FierceBiotech: Allergan bags migraine drug in $1B MAP Pharma buyout. More | Follow @FierceBiotech
@JohnCFierce: Hugin's bold promises on future Celgene revenue face first test with Abraxane pancreatic cancer OS data. News | Follow @JohnCFierce
@RyanMFierce: I'm thinking, at best, Jimenez and Reinhardt are frienemies. Should be interesting to see how this pharma marriage goes. | Follow @RyanMFierce
> Novartis dumps a long-faded $500M pact with Cytos. Story
> Watson beefs up R&D effort with $305M women's health buyout. Report
Drug Delivery News
> Amunix hooks Janssen with its XTEN delivery technology. Story
> Study: Biotronik's dissolving stent deemed safe, falls short of Abbott's Absorb. Article
> Phosphagenics' oxymorphone pain patch close to clinic. Report
> Nanosphere foam delivers drugs to the bladder. News
Biomarkers News
> Researcher spotlights new biomarker for gliomas. Item
> U.K.-based International Diagnostics Centre brings global diagnostics R&D together. Story
> Bill Gates added to investor list in backing genomic tests startup. Report
> Onconova teams with GVK to take cancer biomarkers to IND phase. News
And Finally... Can a dieticians' trade group be objective about nutrition when it's sponsored by Big Food? Report (sub. req.)